Single nucleotide variants (snvs) of angiotensin-converting enzymes (ace1 and ace2): a plausible explanation for the global variation in covid-19 prevalence

HIGHLIGHTS

• who: Saad Mahjub Atiku and collaborators from the Department of Medical Laboratory Sciences, Department of Nursing and Midwifery, Faculty of Health Sciences, Muni University, DL, UK have published the research work: Single Nucleotide Variants (SNVs) of Angiotensin-Converting Enzymes (ACE1 and ACE2): A Plausible Explanation for the Global Variation in COVID-19 Prevalence, in the Journal: Journal of the Renin-Angiotensin-Aldosterone System 90.0 80.0 70.0 % prevalence of 14/Nov/2022
• what: There is sufficient evidence to suggest that the ACE1 II genotype has a relative protective effect against COVID-19 compared . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.